Balanced Rock Investment Advisors’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-83,133
| Closed | -$471K | – | 95 |
|
|
2025
Q3 | $471K | Sell |
83,133
-7,835
| -9% | -$40.1K | 0.34% | 63 |
|
|
2025
Q2 | $347K | Buy |
90,968
+19,768
| +28% | +$61.4K | 0.27% | 76 |
|
|
2025
Q1 | $187K | Buy |
71,200
+838
| +1% | +$2.73K | 0.15% | 86 |
|
|
2024
Q4 | $249K | Buy |
70,362
+5,612
| +9% | +$21.5K | 0.2% | 79 |
|
|
2024
Q3 | $295K | Buy |
64,750
+1,620
| +3% | +$7.84K | 0.23% | 73 |
|
|
2024
Q2 | $275K | Buy |
63,130
+5,882
| +10% | +$25.8K | 0.23% | 71 |
|
|
2024
Q1 | $287K | Buy |
57,248
+4,827
| +9% | +$27K | 0.25% | 75 |
|
|
2023
Q4 | $329K | Buy |
+52,421
| New | +$300K | 0.29% | 75 |
|